We are thrilled to announce that we will be concluding what has been an incredible year of growth for Ginger.io by welcoming Vinod Khosla and his team at Khosla Ventures to the Ginger.io family. We are delighted to announce our $6.5M Series A funding round led by KV. Seed investors True Ventures and Romulus Capital also participated in the round.
Raising a round of financing is a very important decision for any company, and we spent a lot of time thinking if and why this was appropriate. Given our company focus on keeping populations healthy, the incredible client partnerships we’ve built, and the advancements in healthcare reform, we had the opportunity to grow in a way that would allow us to achieve both business and mission-driven goals. Over the next year, we’ll be using the new capital to scale our team, improve our product, and support existing and new partners.
We also spent a lot of time thinking about who were the right partners to help us grow. We have been incredibly fortunate in the time and effort our seed investors and advisors have devoted to our team. With Khosla and True’s focus on true mentorship to their companies, and commitment to disrupt health care, we are confident about our mission of changing how patients are supported away from the doctor’s office.
The most exciting part of this announcement is that we can find more great people to work with. If you are energized by what we are doing, we are actively hiring for engineering and business development roles in both Boston and San Francisco. To learn more about employment opportunities at Ginger.io, visit: http://ginger.io/join-us/.
We are also actively recruiting individuals living with Diabetes, ADHD, Heart disease, and Crohns & Ulcerative Colitis to help us accelerate the development and deployment of the Ginger.io system by becoming early adopters. More information about signing up is available here: http://ginger.io/contribute-to-science/.
For more information, here is our full press release.